This Phase 1 Study will determine the mass balance recovery, absorption, metabolism, and excretion of [14C] Vebicorvir in healthy male subjects

• Consent
• Male between 18 and 55 years of age (inclusive) at the time of Screening
• Body mass index (BMI) between ≥18.0 kg/m2 and ≤32.0 kg/m2 at Screening; body weight between ≥55.0 kg and ≤100.0 kg at Screening
• Considered to be in good health by the Investigator

Exclusion Criteria:

• History or presence of any condition (e.g., chronic diarrhea) or prior surgery (e.g., gastric bypass)
• Clinically significant abnormal medical history
• History of cancer that has not been in full remission for >5 years
• Acute illness within 14 days prior to study drug administration